The first stop for professional medicines advice

Transfer of care

19 results

Applied filters

Worked example of assessing the risk of transcribing

28 January 2025Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.

Offender healthcare settings and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in offender healthcare settings

Transcribing in the patient's home with healthcare input

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input

Non-acute settings with healthcare input and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input

Semi-acute settings and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings

Acute settings and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in acute settings

Risk assessing transcribing for administration

28 January 2025Various factors affect the risks associated with using transcribing for medicines administration.

Alternatives to transcribing for medicines administration

28 January 2025Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.

Understanding transcribing for medicines administration

28 January 2025Transcribing for medicines administration in healthcare requires assessment and mitigation against identified risks. These risks vary according to setting.

National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice

4 August 2020The National Pharmaceutical Supply Group (NPSG) currently advises against participation in advisory boards sponsored by Manufacturers (Marketing Authorisation Holders). This NHMC paper supports this advice…